نتایج جستجو برای: rs1127354

تعداد نتایج: 33  

2014
Ahmad Amanzada Armin D Goralczyk Lars Reinhardt Federico Moriconi Silke Cameron Sabine Mihm

BACKGROUND A decline in hemoglobin (Hb) concentration during antiviral therapy in chronic hepatitis C (CHC) is a serious side effect. It may compel to dose reduction or even termination of antiviral treatment. The activation of erythropoietin (EPO) synthesis as a physiological response to anemia and its relation to a genetic variation within the EPO gene has not been evaluated yet. METHODS Da...

Journal: :Genetics and molecular research : GMR 2017
A V C Coelho S P S Silva L Zandonà G Stocco G Decorti S Crovella

Zidovudine, the antiretroviral drug used to treat HIV infection, commonly causes adverse effects, such as systemic fever and gastrointestinal alterations. In the present study, the potential role of inosine triphosphate pyrophosphatase (ITPA) gene variant on the incidence of adverse events during antiretroviral therapy (ART) of HIV with zidovudine was discussed. Individuals from Northeastern Br...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه تربیت مدرس - دانشکده علوم زیستی 1393

ناباروری به عنوان عدم موفقیت در بارداری بعد از یک سال رابطه جنسی بدون استفاده از روش های جلوگیری از بارداری تعریف می شود. حدود 8 الی 10 درصد زوجین با نوعی مشکل ناباروری مواجه هستند و حدود نیمی از موارد آن با عوامل مردانه است. در حین اسپرماتوژنز در پستانداران از جمله انسان ، سلولهای پیش ساز جنسی مردان دچار تکثیر میتوزی ، تقسیم میتوز و تمایز می شوند تا اسپرم های بالغ و هاپلویید را جهت تولید مثل ج...

Journal: :Journal of hepatology 2013
Monika Rau Felix Stickel Stefan Russmann Christine N Manser Philip P Becker Michael Weisskopf Johannes Schmitt Michael T Dill Jean-François Dufour Darius Moradpour David Semela Beat Müllhaupt Andreas Geier

BACKGROUND & AIMS In the last decade, pegylated interferon-α (PegIFN-α) plus ribavirin (RBV) was the standard treatment of chronic hepatitis C for genotype 1, and it remains the standard for genotypes 2 and 3. Recent studies reported associations between RBV-induced anemia and genetic polymorphisms of concentrative nucleoside transporters such as CNT3 (encoded by SLC28A3) and inosine triphospha...

Journal: :Hepatology 2011
Alexander J Thompson Rosanna Santoro Valeria Piazzolla Paul J Clark Susanna Naggie Hans L Tillmann Keyur Patel Andrew J Muir Kevin V Shianna Leonardo Mottola Daniela Petruzzellis Mario Romano Fernando Sogari Domenico Facciorusso David B Goldstein John G McHutchison Alessandra Mangia

UNLABELLED Two functional variants in the inosine triphosphatase (ITPA) gene causing inosine triphosphatase (ITPase) deficiency protect against ribavirin (RBV)-induced hemolytic anemia and the need for RBV dose reduction in patients with genotype 1 hepatitis C virus (HCV). No data are available for genotype 2/3 HCV. We evaluated the association between the casual ITPA variants and on-treatment ...

2018
Fahimeh Mollaahmadi Ashraf Moini Reza Salman Yazdi Mehrdad Behmanesh

OBJECTIVES Infertility is a common human disorder which is defined as the failure to conceive for a period of 12 months without contraception. Many studies have shown that the outcome of fertility could be affected by DNA damage. We attempted to examine the association of two SNPs (rs1127354 and rs7270101) in ITPA, a gene encoding a key factor in the repair system, with susceptibility to infert...

2015
Sheng-Hung Chen Cheng-Yuan Peng Hsueh-Chou Lai Wen-Pang Su Chia-Hsin Lin Yu-Fen Li Po-Heng Chuang Ching-Hsiang Chen

BACKGROUND Single-nucleotide polymorphisms (SNP) in the inosine triphosphate pyrophosphatase (ITPA) gene correlate with ribavirin (RBV)-induced anemia in patients with chronic hepatitis C (CHC) receiving combination therapy. Managing anemia is an early priority in the treatment process. OBJECTIVES The aim was to develop a predictive index based on ITPA SNP status to identify CHC patients at r...

2014
Alessio Aghemo Eleonora Grassi Maria Grazia Rumi Roberta D'Ambrosio Enrico Galmozzi Elisabetta Degasperi Davide Castaldi Roberta Soffredini Massimo Colombo

BACKGROUND Severe anemia is a common side effect of Pegylated Interferon + Ribavirin (PR) and Telaprevir (TVR) in hepatitis C virus (HCV) genotype 1 patients with advanced fibrosis or cirrhosis (F3-F4). Inosine triphosphatase (ITPA) genetic variants are associated with RBV- induced anemia and dose reduction. AIM To test the association of ITPA polymorphisms rs1127354 and rs7270101 with hemogl...

Journal: :Hepatology 2011
Fumitaka Suzuki Yoshiyuki Suzuki Norio Akuta Hitomi Sezaki Miharu Hirakawa Yusuke Kawamura Tetsuya Hosaka Masahiro Kobayashi Satoshi Saito Yasuji Arase Kenji Ikeda Mariko Kobayashi Kazuaki Chayama Naoyuki Kamatani Yusuke Nakamura Yuzo Miyakawa Hiromitsu Kumada

UNLABELLED Polymorphisms of the inosine triphosphatase (ITPA) gene influence anemia during pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy, but their effects during triple therapy with PEG-IFN, RBV, and telaprevir are not known. Triple therapy for 12 weeks, followed by PEG-IFN and RBV for 12 weeks, was given to 49 patients with RBV-sensitive (CC at rs1127354) and 12 with RBV-resistan...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید